RxDoctor Payments Data

Claudia Smith, NP

Nurse Practitioner · Sonora, CANPI 1780734632

Payments from drug & device makers

$685in general payments, 2019–2025

Across 36 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$149
  • Novo Nordisk$141
  • Lilly USA, LLC$138
  • Amgen$65
  • GSK$39
  • Collegium Pharmaceutical, Inc.$33
  • plus $120 from 5 others

What the payments were for

  • Food & beverage$685100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$685 in reported general payments places this provider in the 70th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Medicare billing

Part B allowed, 2024
$60,704
Medicare patients
273
Services billed
831

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban33$49,593
OzempicSemaglutide18$19,485
TrulicityDulaglutide18$17,363
JardianceEmpagliflozin13$15,165
MounjaroTirzepatide11$11,439
Potassium Chloride100$4,823
Levothyroxine Sodium241$2,710
Atorvastatin Calcium239$2,526
Ezetimibe62$2,389
Albuterol Sulfate HfaAlbuterol Sulfate65$2,281
Estradiol33$1,639
SynthroidLevothyroxine Sodium18$1,379
Benazepril Hcl56$1,104
Lisinopril104$1,029
Losartan Potassium92$995

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$138$28,80229 claims
Novo NordiskOzempic$141$19,48518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Sonora

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →